[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-194682-105":3,"detail-sidebar-cat-1-en-105":73,"doc-detail-194682-en":118},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","kansas-medical-care-facility-drug-diversion-reporting-flowchart-march-2023","Kansas Medical Care Facility Drug Diversion Reporting Flowchart - March 2023","","This document outlines the reporting flowchart for drug diversion incidents within Kansas medical care facilities, effective March 2023. It details the procedures for reporting drug diversion by healthcare providers occurring outside the medical facility, as well as when drug diversion occurs within the facility. The flowchart specifies reporting requirements based on the knowledge of healthcare providers, medical facility employees, licensees of the Kansas Board of Nursing, and hospital agents or employees. It also addresses situations involving abuse or neglect of minors or adults, and drug diversion at long-term care facilities. The document clarifies when to report to the CEO, CMO, Risk Manager, executive committees, state licensing agencies, the Department of Children and Families (DCF), local law enforcement, HHS, KDADS, DEA, the Board of Pharmacy, and the Kansas Department of Health and Environment (KDHE). Furthermore, it details the requirements for making adverse incident reports with KDADS and submitting Form 106 to the DEA and Board of Pharmacy within one business day when informed of theft or significant loss of controlled substances.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/general/","General",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/kansas-medical-care-facility-drug-diversion-reporting-flowchart-march-2023/194682/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/kansas-medical-care-facility-drug-diversion-reporting-flowchart-march-2023/194682.png","ImageObject",442,249,{"name":42,"@type":43},"Connor ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-09-29","2026-09-03",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What steps must be taken if there is knowledge of theft or significant loss of controlled substances?","Question",{"text":63,"@type":64},"If a hospital agent, employee, DEA registrant, or pharmacist has knowledge of theft or significant loss of controlled substances, it must be reported. Specifically, a pharmacist-in-charge or pharmacy must prepare and submit Form 106 within one business day to the DEA and the Board of Pharmacy, and also report to the individual responsible for the pharmaceutical service and the chief executive officer.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},194682,1788441624,{"code":4,"msg":74,"data":75},"success",[76,81,86,91,96,101,106,111,115],{"id":77,"doc_module":22,"doc_module_name":25,"category_name":78,"show_sort_weight":79,"slug":80},11,"Presentations",90,"presentations",{"id":82,"doc_module":22,"doc_module_name":25,"category_name":83,"show_sort_weight":84,"slug":85},12,"Resumes",80,"resumes",{"id":87,"doc_module":22,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},14,"Invoices",70,"invoices",{"id":92,"doc_module":22,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},15,"Posters",60,"posters",{"id":97,"doc_module":22,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},16,"Social Media",50,"social-media",{"id":102,"doc_module":22,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},17,"Forms",40,"forms",{"id":107,"doc_module":22,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},18,"Letters",30,"letters",{"id":112,"doc_module":22,"doc_module_name":25,"category_name":113,"show_sort_weight":55,"slug":114},21,"Paper Templates","papers-templates",{"id":116,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":4,"slug":117},158,"general-158",{"code":4,"msg":74,"data":119},{"doc_id":71,"user_id":120,"nickname":42,"user_avatar":121,"doc_module":22,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":11,"file_id":122,"file_url":123,"file_type":124,"file_size":125,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":22,"language":126,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":127,"faqs":128,"seo_title":129,"seo_description":12,"update_tm":72,"read_time":4},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","cbCaieseOQn2CyIm","https://ap.wps.com/l/cbCaieseOQn2CyIm","pdf",105125,"English","# Drug Diversion Reporting Flowchart","[{\"question\":\"What steps must be taken if there is knowledge of theft or significant loss of controlled substances?\",\"answer\":\"If a hospital agent, employee, DEA registrant, or pharmacist has knowledge of theft or significant loss of controlled substances, it must be reported. Specifically, a pharmacist-in-charge or pharmacy must prepare and submit Form 106 within one business day to the DEA and the Board of Pharmacy, and also report to the individual responsible for the pharmaceutical service and the chief executive officer.\"}]","Kansas Medical Care Facility Drug Diversion Reporting Flowchart - March 2023 | PDF"]